Neuraxial anesthesia for labor and cesarean delivery in a parturient with hereditary antithrombin deficiency on recombinant human antithrombin infusion therapy

Journal of Clinical Anesthesia

Volumn 22, Issue 6, 2010, Pages 450-453

  Pamnani, Anup ^a   Rosenstein, Megan ^b   Darwich, Alaeldin ^a   Wolfson, Alexander ^c  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b Summit Anesthesia Associates   (United States)

^c Princeton Healthcare Services   (United States)

Author keywords

Analgesia, obstetric, labor; Antithrombin Alfa; Antithrombin deficiency; Cesarean delivery; Epidural catheter; Recombinant human antithrombin

Indexed keywords

ANTITHROMBIN; ANTITHROMBIN ALFA; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; UNCLASSIFIED DRUG;

ADULT; ANTICOAGULATION; ANTITHROMBIN DEFICIENCY; ARTICLE; CASE REPORT; CESAREAN SECTION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; EPIDURAL ANESTHESIA; FEMALE; HUMAN; LABOR INDUCTION; PREGNANCY; PRIORITY JOURNAL;

ADULT; ANESTHESIA, EPIDURAL; ANTITHROMBIN III DEFICIENCY; ANTITHROMBINS; CESAREAN SECTION; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RECOMBINANT PROTEINS;

EID: 77957155850     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinane.2009.05.008     Document Type: Article

References (20)

1. Perry D.J. Antithrombin and its inherited deficiencies Blood Rev 8 1994 37 55
2. Rosenberg R.D. Actions and interactions of antithrombin III and heparin N Engl J Med 292 1975 146 151
3. Bayson T., and Lane D. Antithrombin Mutation Database Available at: http://www1.imperial.ac.uk/medicine/about/divisions/is/haemo/coag/antithrombin/ Accessed March 22, 2009
4. Hirsh J., Piovella F., and Pini M. Congenital antithrombin III deficiency. Incidence and clinical features Am J Med 87 3B 1989 34S 38S
5. McColl M.D., Ramsay J.E., and Tait R.C. Risk factors for pregnancy associated venous thromboembolism Thromb Haemost 78 1997 1183 1188
6. Hunt B.J., Doughty H.A., and Majumdar G. Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies Thromb Haemost 77 1997 39 43
7. Frydman A. Low-molecular-weight heparins: an overview of their pharmacodynamics, pharmacokinetics and metabolism in humans Haemostasis 26 Suppl 2 1996 24 38
8. Ellison J., Walker I.D., and Greer I.A. Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy BJOG 107 2000 1116 1121
9. Thomson A.J., Walker I.D., and Greer I.A. Low-molecular-weight heparin for immediate management of thromboembolic disease in pregnancy Lancet 352 9144 1998 1904
10. Shefras J., and Farquharson R.G. Bone density studies in pregnant women receiving heparin Eur J Obstet Gynecol Reprod Biol 65 1996 171 174
11. Birnbach D.J., and Grunebaum A. The anticoagulated parturient S. Datta, Anesthetic and Obstetric Management of High-Risk Pregnancy 1991 Mosby Year Book St. Louis (Mo) 522 535
12. Horlocker T.T., Wedel D.J., and Benzon H. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation) Reg Anesth Pain Med 28 2003 172 197
13. Duhl A.J., Paidas M.J., Ural S.H. Pregnancy and Thrombosis Working Group Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcome Am J Obstet Gynecol 197 2007 457.e1 457.e21
14. Edmunds T., Van Patten S.M., and Pollock J. Transgenically produced human antithrombin: structural and functional comparison to human plasma-derived antithrombin Blood 91 1998 4561 4571
15. Tiede A., Tait R.C., and Shaffer D.W. Antithrombin alfa in hereditary antithrombin deficient patients: a phase 3 study of prophylactic intravenous administration in high risk situations Thromb Haemost 99 2008 616 622
16. Hellgren M., Tengborn L., and Abildgaard U. Pregnancy in women with congenital antithrombin III deficiency: experience of treatment with heparin and antithrombin Gynecol Obstet Invest 14 1982 127 141
17. Konkle B.A., Bauer K.A., Weinstein R., Greist A., Holmes H.E., and Bonfiglio J. Use of recombinant human antithrombin in patients with congenital antithrombin deficiency undergoing surgical procedures Transfusion 43 2003 390 394
18. Knight R., Stanley S., Wong M., and Dolan G. Hemophilia therapy and blood-borne pathogen risk Semin Thromb Hemost 32 Suppl 2 2006 3 9
19. Chang W.S., and Harper P.L. Commercial antithrombin concentrate contains inactive L-forms of antithrombin Thromb Haemost 77 1997 323 328
20. Menache D. Replacement therapy in patients with hereditary antithrombin III deficiency Semin Hematol 28 1991 31 38